Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis

被引：0
作者：
Daniel H. Li
Erika Lee
Christine Song
机构：
[1] University of Toronto,Division of Clinical Immunology and Allergy, Department of Medicine
来源：
Allergy, Asthma & Clinical Immunology | / 18卷
关键词：
COVID-19; mRNA vaccine; Anaphylaxis; Excipient testing; Polyethylene glycol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 35 条
  • [1] Gee J(2021)First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020-January 13, 2021 MMWR Morb Mortal Wkly Rep 70 283-288
  • [2] Marquez P(2021)mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach J Allergy Clin Immunol Pract 9 1423-1437
  • [3] Su J(2021)Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine Clin Exp Allergy 51 861-863
  • [4] Calvert GM(2021)Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines With confirmatory testing in a US regional health system JAMA Netw Open 4 3308-20.e3
  • [5] Liu R(2021)First-dose mRNA COVID-19 vaccine allergic reactions: limited role for excipient skin testing J Allergy Clin Immunol Pract 9 620-5.e1
  • [6] Myers T(2022)Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: a case series J Allergy Clin Immunol Pract 10 undefined-undefined
  • [7] Banerji A(undefined)undefined undefined undefined undefined-undefined
  • [8] Wickner PG(undefined)undefined undefined undefined undefined-undefined
  • [9] Saff R(undefined)undefined undefined undefined undefined-undefined
  • [10] Stone CA(undefined)undefined undefined undefined undefined-undefined
1234